martin roger's reply - re usa analysts

One of my mates, let's call him "John", emailed Martin, and MR replied.

The way I read it - BNYM or market-makers will initiate and release analyst's report real soon.

Watch!


-------- Original Message --------
Subject:
Re: Shares plummet after Prima BioMed US listing-SMH- 23/4/12
Date: Mon, 23 Apr 2012 23:17:34 +1000
From: Martin Rogers
To: "John"


Hi “John”

Thank you for your email. I am overseas at the moment.

Our goal is to have US analysts cover our stock on the NASDAQ and this is certainly not going to happen overnight but we are of great interest being an potential blockbuster cancer drug.


Please see the Nomura research report that the journalist mentioned. As you can see it is a rather one sided opinion.

Your support is much appreciated and we couldn't do the work with do without the support of investors.

Best regards, Martin

-----------------------

On Mon, Apr 23, 2012 at 7:58 PM, “John” wrote:


Good evening Martin

Do you have USA research report to counter the SMH's coverage today.

Regards,
“John”


Shares plummet after Prima BioMed US listing

www.smh.com.au/business/shares-plummet-after-prima-biomed-us-listing-20120422-1xewd.html